Beta-Caryophyllene: Terpene Powerhouse
Project CBD
JUNE 7, 2023
And a December 2022 article in Current Neuropharmacology, 9 by researchers in Brazil, investigated BCP’s potential “as a new drug for the treatment of substance use disorders.” Medical scientists are studying beta-caryophyllene as a treatment for non-alcoholic fatty liver disease, chronic pain, and substance abuse. PloS one vol.
Let's personalize your content